Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study-Reference-Cited by-同舟云学术

Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study

Published:2023-03 Issue:3 Volume:24 Page:252-261
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Mauz-Körholz Christine,Landman-Parker Judith,Fernández-Teijeiro Ana,Attarbaschi Andishe,Balwierz Walentyna,Bartelt Jörg M,Beishuizen Auke,Boudjemaa Sabah,Cepelova Michaela,Ceppi Francesco,Claviez Alexander,Daw Stephen,Dieckmann Karin,Fosså Alexander,Gattenlöhner Stefan,Georgi Thomas,Hjalgrim Lisa L,Hraskova Andrea,Karlén Jonas,Kurch Lars,Leblanc Thierry,Mann Georg,Montravers Francoise,Pears Jane,Pelz Tanja,Rajić Vladan,Ramsay Alan D,Stoevesandt Dietrich,Uyttebroeck Anne,Vordermark Dirk,Körholz Dieter,Hasenclever Dirk,Wallace William H,Kluge Regine

Publisher

Elsevier BV

Subject

Oncology

Reference26 articles.

1. Combined treatment strategy in over 200 children with Hodgkin's disease: graduated chemotherapy, involved field irradiation with low dosage and selective splenectomy. A report of the cooperative therapy study DAL-HD-82;Schellong;Klin Padiatr,1986

2. High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90;Schellong;J Clin Oncol,1999

3. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study;Weiner;J Clin Oncol,1997

4. VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial;Donaldson;J Clin Oncol,2002

5. A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425;Schwartz;Blood,2009

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A combination strategy of DOX and VEGFR-2 targeted inhibitor based on nanomicelle for enhancing lymphoma therapy;Chinese Chemical Letters;2024-12

2. Hodgkin lymphoma involving the extra-axial CNS: an AHOD1331, PHL-C1, and PHL-C2 report from the COG and EuroNet-PHL;Blood Advances;2024-09-24

3. Symptomatic osteonecrosis in children treated for Hodgkin lymphoma: A population‐based study in Sweden, Finland, and Denmark;Pediatric Blood & Cancer;2024-08-14

4. Hodgkin lymphoma: hypodense lesions in mediastinal masses;Scientific Reports;2024-06-25

5. Novel immunotherapeutic approaches for pediatric classical Hodgkin lymphoma: Nivolumab or brentuximab vedotin with the AVD regimen;Pediatric Blood & Cancer;2024-06-05